PURPOSE OF REVIEW: Stearoyl-coenzyme A desaturase 1 is a delta-9 fatty acid desaturase that catalyzes the synthesis of monounsaturated fatty acids and has emerged as a key regulator of metabolism. This review evaluates the latest advances in our understanding of the pivotal role of stearoyl-coenzyme A desaturase 1 in health and disease. RECENT FINDINGS: Scd1-deficient mice have reduced lipid synthesis and enhanced lipid oxidation, thermogenesis and insulin sensitivity in various tissues including liver, muscle and adipose tissue due to transcriptional and posttranscriptional effects. These metabolic changes protect Scd1-deficient mice from a variety of dietary, pharmacological and genetic conditions that promote obesity, insulin resistance and hepatic steatosis. Stearoyl-coenzyme A desaturase 1 is required to guard against dietary unsaturated fat deficiency, leptin deficiency-induced diabetes, and palmitate-induced lipotoxic insults in muscle and pancreatic beta-cells. Paradoxical observations of increased muscle stearoyl-coenzyme A desaturase 1 during obesity, starvation and exercise raise questions as to the role of stearoyl-coenzyme A desaturase 1 in this tissue. Mice with a liver-specific loss of stearoyl-coenzyme A desaturase 1, and inhibition of stearoyl-coenzyme A desaturase 1 via antisense or RNA interference, recapitulate only a subset of the phenotypes observed in global Scd1 deficiency, indicating the involvement of multiple tissues. SUMMARY: Recent studies in humans and animal models have highlighted that modulation of stearoyl-coenzyme A desaturase 1 activity by dietary intervention or genetic manipulation strongly influences several facets of energy metabolism to affect susceptibility to obesity, insulin resistance, diabetes and hyperlipidemia.
PURPOSE OF REVIEW: Stearoyl-coenzyme A desaturase 1 is a delta-9 fatty acid desaturase that catalyzes the synthesis of monounsaturated fatty acids and has emerged as a key regulator of metabolism. This review evaluates the latest advances in our understanding of the pivotal role of stearoyl-coenzyme A desaturase 1 in health and disease. RECENT FINDINGS:Scd1-deficient mice have reduced lipid synthesis and enhanced lipid oxidation, thermogenesis and insulin sensitivity in various tissues including liver, muscle and adipose tissue due to transcriptional and posttranscriptional effects. These metabolic changes protect Scd1-deficient mice from a variety of dietary, pharmacological and genetic conditions that promote obesity, insulin resistance and hepatic steatosis. Stearoyl-coenzyme A desaturase 1 is required to guard against dietary unsaturated fat deficiency, leptin deficiency-induced diabetes, and palmitate-induced lipotoxic insults in muscle and pancreatic beta-cells. Paradoxical observations of increased muscle stearoyl-coenzyme A desaturase 1 during obesity, starvation and exercise raise questions as to the role of stearoyl-coenzyme A desaturase 1 in this tissue. Mice with a liver-specific loss of stearoyl-coenzyme A desaturase 1, and inhibition of stearoyl-coenzyme A desaturase 1 via antisense or RNA interference, recapitulate only a subset of the phenotypes observed in global Scd1 deficiency, indicating the involvement of multiple tissues. SUMMARY: Recent studies in humans and animal models have highlighted that modulation of stearoyl-coenzyme A desaturase 1 activity by dietary intervention or genetic manipulation strongly influences several facets of energy metabolism to affect susceptibility to obesity, insulin resistance, diabetes and hyperlipidemia.
Authors: Tony K T Lam; Roger Gutierrez-Juarez; Alessandro Pocai; Sanjay Bhanot; Patrick Tso; Gary J Schwartz; Luciano Rossetti Journal: Nat Med Date: 2007-02-04 Impact factor: 53.440
Authors: P Sjögren; J Sierra-Johnson; K Gertow; M Rosell; B Vessby; U de Faire; A Hamsten; M-L Hellenius; R M Fisher Journal: Diabetologia Date: 2007-11-20 Impact factor: 10.122
Authors: Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown Journal: J Biol Chem Date: 2002-01-08 Impact factor: 5.157
Authors: Edward A Dennis; Raymond A Deems; Richard Harkewicz; Oswald Quehenberger; H Alex Brown; Stephen B Milne; David S Myers; Christopher K Glass; Gary Hardiman; Donna Reichart; Alfred H Merrill; M Cameron Sullards; Elaine Wang; Robert C Murphy; Christian R H Raetz; Teresa A Garrett; Ziqiang Guan; Andrea C Ryan; David W Russell; Jeffrey G McDonald; Bonne M Thompson; Walter A Shaw; Manish Sud; Yihua Zhao; Shakti Gupta; Mano R Maurya; Eoin Fahy; Shankar Subramaniam Journal: J Biol Chem Date: 2010-10-05 Impact factor: 5.157
Authors: Woo Jung Park; Kumar S D Kothapalli; Holly T Reardon; Peter Lawrence; Shu-Bing Qian; J Thomas Brenna Journal: J Lipid Res Date: 2012-05-22 Impact factor: 5.922
Authors: Tomas Majtan; Wendell Jones; Jakub Krijt; Insun Park; Warren D Kruger; Viktor Kožich; Steven Bassnett; Erez M Bublil; Jan P Kraus Journal: Mol Ther Date: 2017-12-19 Impact factor: 11.454
Authors: M Kunešová; P Hlavatý; E Tvrzická; B Staňková; P Kalousková; N Viguerie; T M Larsen; M A van Baak; S A Jebb; J A Martinez; A F H Pfeiffer; A Kafatos; T Handjieva-Darlenska; M Hill; D Langin; A Zák; A Astrup; W H M Saris Journal: Physiol Res Date: 2012-10-25 Impact factor: 1.881
Authors: Lawal Garba; Mohd Shukuri Mohamad Ali; Siti Nurbaya Oslan; Raja Noor Zaliha Raja Abdul Rahman Journal: Mol Biotechnol Date: 2016-11 Impact factor: 2.695
Authors: Jingzhong Ding; Lindsay M Reynolds; Tanja Zeller; Christian Müller; Kurt Lohman; Barbara J Nicklas; Stephen B Kritchevsky; Zhiqing Huang; Alberto de la Fuente; Nicola Soranzo; Robert E Settlage; Chia-Chi Chuang; Timothy Howard; Ning Xu; Mark O Goodarzi; Y-D Ida Chen; Jerome I Rotter; David S Siscovick; John S Parks; Susan Murphy; David R Jacobs; Wendy Post; Russell P Tracy; Philipp S Wild; Stefan Blankenberg; Ina Hoeschele; David Herrington; Charles E McCall; Yongmei Liu Journal: Diabetes Date: 2015-07-07 Impact factor: 9.461